Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W I Bensinger

Showing results (61-70 of 152) with videos related to

Pageof 16
Sort By:
The American Journal of Surgical Pathology|July 15, 2000
Bile duct apoptosis and cholestasis resembling acute graft-versus-host disease after autologous hematopoietic cell transplantationM D Saunders, H M Shulman, C S Murakami, et al.
Bone Marrow Transplantation|January 18, 2006
Reliability and validity of a patient self-administered daily questionnaire to assess impact of oral mucositis (OM) on pain and daily functioning in patients undergoing autologous hematopoietic stem cell transplantation (HSCT)P J Stiff, H Erder, W I Bensinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancerT Demirer, S Rowley, C D Buckner, et al.
Gene Therapy|January 24, 2014
Immune escape from NY-ESO-1-specific T-cell therapy via loss of heterozygosity in the MHCZ K Klippel, J Chou, A M Towlerton, et al.
American Journal of Clinical Oncology|August 24, 2000
Pilot trial of cytoprotection with amifostine given with high-dose chemotherapy and autologous peripheral blood stem cell transplantationT R Chauncey, T A Gooley, M E Lloid, et al.
British Journal of Haematology|May 31, 2001
A proposed objective way to assess results of randomized prospective clinical trials with acute graft-versus-host disease as an outcome of interestH Al-Ghamdi, W Leisenring, W I Bensinger, et al.
Bone Marrow Transplantation|June 13, 2000
Enumeration of HPC in mobilized peripheral blood with the Sysmex SE9500 predicts final CD34+ cell yield in the apheresis collectionJ Yu, W Leisenring, W Fritschle, et al.
The Journal of Clinical Investigation|March 1, 1988
Antigen CD34+ marrow cells engraft lethally irradiated baboonsR J Berenson, R G Andrews, W I Bensinger, et al.
Blood|March 15, 1995
Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factorW I Bensinger, C H Weaver, F R Appelbaum, et al.
Bone Marrow Transplantation|March 1, 1996
Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levelsT Demirer, C D Buckner, F R Appelbaum, et al.
Pageof 16

Showing results (61-70 of 152) with videos related to

Sort By:
Pageof 16
The American Journal of Surgical Pathology|July 15, 2000
Bile duct apoptosis and cholestasis resembling acute graft-versus-host disease after autologous hematopoietic cell transplantationM D Saunders, H M Shulman, C S Murakami, et al.
Bone Marrow Transplantation|January 18, 2006
Reliability and validity of a patient self-administered daily questionnaire to assess impact of oral mucositis (OM) on pain and daily functioning in patients undergoing autologous hematopoietic stem cell transplantation (HSCT)P J Stiff, H Erder, W I Bensinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancerT Demirer, S Rowley, C D Buckner, et al.
Gene Therapy|January 24, 2014
Immune escape from NY-ESO-1-specific T-cell therapy via loss of heterozygosity in the MHCZ K Klippel, J Chou, A M Towlerton, et al.
American Journal of Clinical Oncology|August 24, 2000
Pilot trial of cytoprotection with amifostine given with high-dose chemotherapy and autologous peripheral blood stem cell transplantationT R Chauncey, T A Gooley, M E Lloid, et al.
British Journal of Haematology|May 31, 2001
A proposed objective way to assess results of randomized prospective clinical trials with acute graft-versus-host disease as an outcome of interestH Al-Ghamdi, W Leisenring, W I Bensinger, et al.
Bone Marrow Transplantation|June 13, 2000
Enumeration of HPC in mobilized peripheral blood with the Sysmex SE9500 predicts final CD34+ cell yield in the apheresis collectionJ Yu, W Leisenring, W Fritschle, et al.
The Journal of Clinical Investigation|March 1, 1988
Antigen CD34+ marrow cells engraft lethally irradiated baboonsR J Berenson, R G Andrews, W I Bensinger, et al.
Blood|March 15, 1995
Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factorW I Bensinger, C H Weaver, F R Appelbaum, et al.
Bone Marrow Transplantation|March 1, 1996
Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levelsT Demirer, C D Buckner, F R Appelbaum, et al.
Pageof 16